Literature DB >> 11422442

Comparison of the aggregation properties, secondary structure and apoptotic effects of wild-type, Flemish and Dutch N-terminally truncated amyloid beta peptides.

N Demeester1, C Mertens, H Caster, M Goethals, J Vandekerckhove, M Rosseneu, C Labeur.   

Abstract

The Dutch (E22Q) and Flemish (A21G) mutations in the betaAPP region of the amyloid precursor protein (APP) are associated with familial forms of Alzheimer dementia. However, patients with these mutations express substantially different clinical phenotypes. Therefore, secondary structure and cytotoxic effects of the three Abeta(12-42) variants [wild-type (WT), Dutch and Flemish] were tested. At a concentration of 5 microM the aggregation of these peptides followed the order: Abeta(1-42) WT > Abeta(12-42) WT > Abeta(12-42) Flemish > Abeta(12-42) Dutch. The stability of the secondary structure of these peptides upon decreasing the trifluoroethanol (TFE) concentration in the buffer was followed by circular dichroism measurements. WT peptides progressively lost their alpha-helical structure; this change occurred faster for both the Flemish and Dutch peptides, and at higher percentages of TFE in the buffer, and was accompanied by an increase in beta-sheet and random coil content. Apoptosis was induced in neuronal cells by the Abeta(12-42) WT and Flemish peptides at concentrations as low as 1-5 microM, as evidenced by propidium iodide (PI) staining, DNA laddering and caspase-3 activity measurements. Even when longer incubation times and higher peptide concentrations were applied the N-truncated Dutch peptide did not induce apoptosis. Apoptosis induced by the full length Abeta(1-42) peptide was weaker than that induced by its N-truncated variant. These data suggest that N-truncation enhanced the cytotoxic effects of Abeta WT and Flemish peptides, which may play a role in the accelerated progression of dementia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422442     DOI: 10.1046/j.0953-816x.2001.01579.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  13 in total

1.  β-Amyloid carrying the Dutch mutation has diverse effects on calpain-mediated toxicity in hippocampal neurons.

Authors:  Alexandra M Nicholson; Lindsey A Wold; Dominic M Walsh; Adriana Ferreira
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

2.  Adsorption mechanism and collapse propensities of the full-length, monomeric Aβ(1-42) on the surface of a single-walled carbon nanotube: a molecular dynamics simulation study.

Authors:  Asis K Jana; Neelanjana Sengupta
Journal:  Biophys J       Date:  2012-04-18       Impact factor: 4.033

3.  Polymorphic triple beta-sheet structures contribute to amide hydrogen/deuterium (H/D) exchange protection in the Alzheimer amyloid beta42 peptide.

Authors:  Buyong Ma; Ruth Nussinov
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

4.  Point mutations in Aβ induce polymorphic aggregates at liquid/solid interfaces.

Authors:  Elizabeth A Yates; Elena M Cucco; Justin Legleiter
Journal:  ACS Chem Neurosci       Date:  2011-04-11       Impact factor: 4.418

5.  Differential contribution of isoaspartate post-translational modifications to the fibrillization and toxic properties of amyloid β and the Asn23 Iowa mutation.

Authors:  Silvia Fossati; Krysti Todd; Krystal Sotolongo; Jorge Ghiso; Agueda Rostagno
Journal:  Biochem J       Date:  2013-12-15       Impact factor: 3.857

6.  Lipid-induced conformational transition of amyloid beta peptide fragments.

Authors:  Nagarajan Sureshbabu; R Kirubagaran; H Thangarajah; E J Padma Malar; R Jayakumar
Journal:  J Mol Neurosci       Date:  2010-05-18       Impact factor: 3.444

7.  Mishandling of the therapeutic peptide glucagon generates cytotoxic amyloidogenic fibrils.

Authors:  Satomi Onoue; Keiichi Ohshima; Kazuhiro Debari; Keitatsu Koh; Seiji Shioda; Sumiko Iwasa; Kazuhisa Kashimoto; Takehiko Yajima
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

8.  Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β'-site increases Aβ generation.

Authors:  Lujia Zhou; Nathalie Brouwers; Iryna Benilova; Annelies Vandersteen; Marc Mercken; Koen Van Laere; Philip Van Damme; David Demedts; Fred Van Leuven; Kristel Sleegers; Kerensa Broersen; Christine Van Broeckhoven; Rik Vandenberghe; Bart De Strooper
Journal:  EMBO Mol Med       Date:  2011-04-15       Impact factor: 12.137

9.  Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model.

Authors:  Oliver Wirths; Henning Breyhan; Holger Cynis; Stephan Schilling; Hans-Ulrich Demuth; Thomas A Bayer
Journal:  Acta Neuropathol       Date:  2009-06-23       Impact factor: 17.088

Review 10.  APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.

Authors:  Leslie Crews; Edward Rockenstein; Eliezer Masliah
Journal:  Brain Struct Funct       Date:  2009-11-29       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.